These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16759163)

  • 1. Present and potential future issues in glioblastoma treatment.
    Lefranc F; Sadeghi N; Camby I; Metens T; Dewitte O; Kiss R
    Expert Rev Anticancer Ther; 2006 May; 6(5):719-32. PubMed ID: 16759163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glioblastoma treatment in 2010].
    Djedid R; Tomasi O; Haidara A; Rynkowski M; Lefranc F
    Rev Med Brux; 2009; 30(5):496-505. PubMed ID: 19998795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in therapy for glioblastoma.
    Clarke J; Butowski N; Chang S
    Arch Neurol; 2010 Mar; 67(3):279-83. PubMed ID: 20212224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies for inhibiting invasion in glioblastoma.
    Drappatz J; Norden AD; Wen PY
    Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis.
    Lefranc F; Brotchi J; Kiss R
    J Clin Oncol; 2005 Apr; 23(10):2411-22. PubMed ID: 15800333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New therapeutic approaches in glioblastomas].
    Le Guilloux J; Carpentier AF
    Rev Neurol (Paris); 2008; 164(6-7):554-9. PubMed ID: 18565354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of malignant glioma: steady progress with multimodal approaches.
    Ashby LS; Ryken TC
    Neurosurg Focus; 2006 Apr; 20(4):E3. PubMed ID: 16709034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular advances of brain tumors in radiation oncology.
    Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
    Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of recent data on the optimization of standards of care in newly diagnosed glioblastoma.
    Cloughesy T
    Semin Oncol; 2011 Dec; 38 Suppl 4():S11-20. PubMed ID: 22078643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options for recurrent glioblastoma: pitfalls and future trends.
    Franceschi E; Tosoni A; Bartolini S; Mazzocchi V; Fioravanti A; Brandes AA
    Expert Rev Anticancer Ther; 2009 May; 9(5):613-9. PubMed ID: 19445578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative follow-up of enhancement phenomena with MRI and Proton MR Spectroscopic Imaging after intralesional immunotherapy in glioblastoma--Report of two exceptional cases.
    Floeth FW; Wittsack HJ; Engelbrecht V; Weber F
    Zentralbl Neurochir; 2002; 63(1):23-8. PubMed ID: 12098080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.
    Quant EC; Wen PY
    Neuroimaging Clin N Am; 2010 Aug; 20(3):425-48. PubMed ID: 20708556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas.
    Sanghera P; Rampling R; Haylock B; Jefferies S; McBain C; Rees JH; Soh C; Whittle IR
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):216-27. PubMed ID: 21783349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New chemotherapy options for the treatment of malignant gliomas.
    Soffietti R; Rudà R; Trevisan E
    Anticancer Drugs; 2007 Jul; 18(6):621-32. PubMed ID: 17762390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapies for malignant gliomas.
    Cavaliere R; Wen PY; Schiff D
    Neurol Clin; 2007 Nov; 25(4):1141-71, x. PubMed ID: 17964029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes in glioblastoma multiforme, including the impact of adjuvant chemotherapy.
    Blumenthal DT; Schulman SF
    Expert Rev Neurother; 2005 Sep; 5(5):683-90. PubMed ID: 16162092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
    Lefranc F; Rynkowski M; DeWitte O; Kiss R
    Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New therapeutic options in therapy of glioblastoma multiforme].
    Lakomý R; Burkon P; Burkonová D; Jancálek R
    Klin Onkol; 2010; 23(6):381-7. PubMed ID: 21351415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
    Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma multiforme: evidence-based approach to therapy.
    Nicholas MK
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.